Contify battlecard: recent moves and reviews

Contify is a market and competitive intelligence platform vendor whose recent activity centres on product redesign, AI distribution and a sharper pharmaceutical focus. Its moves over the past few months show a company repositioning both its interface and its route to buyers. The 12 tracked moves include 2 confirmed items, giving a useful mix of announced events and observed signals.

Watching Contify now matters because several moves land close together. A platform redesign, an AI integration and a vertical rebrand all point to a coordinated push rather than isolated updates. For anyone benchmarking the M&CI vendor landscape, these shifts are worth reading as one story.

Product and interface overhaul: Contify shipped a redesigned dashboard with enhanced Athena AI capabilities in mid August 2026. It then released an October 2026 update carrying a full platform UI/UX redesign. Two interface moves in quick succession suggest the vendor is consolidating its product experience rather than adding features piecemeal. The Athena AI work signals that AI assistance is now core to the platform, not a side module.

Distribution through AI ecosystems: In late September 2026 Contify launched an MCP server piping intelligence into ChatGPT and Claude. This is a notable distribution play, placing Contify's output inside tools buyers already use daily. Combined with the Athena work, it shows a strategy of meeting users in their existing workflows. The vendor is positioning itself as an intelligence source rather than only a destination platform.

Sharper pharmaceutical focus: In late August 2026 Contify rebranded its healthcare vertical to pharmaceuticals as a GTM refinement. Days earlier it targeted pharma M&A teams with a contextual competitor acquisition analysis angle. The pairing shows deliberate narrowing toward higher-value pharmaceutical use cases. This is a classic vertical concentration move, trading breadth for depth in a lucrative segment.

Marketing, talent and competitive positioning: Contify posted three Gurugram roles in late October 2026, including a marketing director. It also targeted AI answer engines through new marketing hires focused on GEO and AEO in mid August 2026. In late September 2026 it published two comparison posts, one aimed at Klue users. These moves point to an aggressive demand-generation push aimed at rivals and at AI-driven discovery channels.

Signals of internal strain: Glassdoor reviews skew 5-star, yet two 1-star entries cite marketing churn in early October 2026. An earlier observed pattern in mid August 2026 alleged high turnover in the marketing department. These signals sit awkwardly beside the hiring and rebrand push. They suggest execution risk in the very function now carrying the GTM message.

What to watch: Watch whether the November 2026 webinar on the new M&CI platform converts the redesign into clear buyer messaging. Track whether the pharmaceutical focus produces named use cases beyond M&A analysis. Also monitor whether marketing hiring stabilises the churn signals or deepens them.